Health & Fitness
Fri, February 24, 2012
BOULDER, Colo.--([ BUSINESS WIRE ])--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its fourth quarter and year-end 2011 financial results on Thursday, March 8, 2012, before the open of the U.S. financial markets. Clovisa senior management will host a conference call and live audio webcast on Thursday, March 8, at 8:30 a.m. ET to discuss the companyas results in greater detail.
The financial results conference call is being webcast and can be accessed from the Clovis Oncology website at [ www.clovisoncology.com ]. A replay of the webcast will be available for 30 days.
In addition, company management will present at the Cowen and Company 32nd Annual Health Care Conference on Tuesday, March 6, 2012 at 8:40 AM Eastern Time. The conference will be held at the Marriott Copley Place in Boston.
The presentation is being webcast and can be accessed from the Clovis Oncology website at [ www.clovisoncology.com ]. A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.
